Gossamer Bio and Chiesi Ink Pact To Develop Seralutinib in PAH

Gossamer Bio, Inc. (Gossamer), a clinical-stage biopharmaceutical organization centered on the progression and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Farmaceutici S.p.A (Chiesi Gathering)...

EMA Approves Bristol Myers's Application For Opdivo Plus Yervoy

Bristol Myers Squibb, a pharmaceutical firm, reported that the European Medicines Agency (EMA) has approved its Sort II variation application for Opdivo (nivolumab) in addition to Yervoy (ipilimumab) for the first-line therapy of grown-up patients...

Naprod Life Sciences successfully renews EU GMP Certification for its Palghar facility

Naprod Life Sciences (Naprod) announced today the successful renewal of its European Union Goods Manufacturing Practices (EU-GMP) certification for its manufacturing facility in Palghar.

Mediar Commences Patient dosing in US FDA Approved Phase 1 Trial

Mediar Therapeutics, Inc., a biotechnology company developing a portfolio of first-in-class therapies to halt fibrosis progression, reported that the first cohort of participants in a phase 1 trial evaluating the safety and tolerability of MTX-463...

ASPA Launches Public Awareness Campaign for Counterfeit Drugs

The Authentication Solution Providers' Association (ASPA), a proactive advocate in the fight against counterfeiting, spearheads a robust public awareness campaign, particularly within the pharmaceutical industry. Recognising the urgent need to add...

Emcure Pharmaceuticals Unveils Campaign 'Cure and Beyond' Featuring MS Dhoni

Emcure Pharmaceuticals, one of India’s leading pharmaceutical companies, unveiled its new corporate campaign with the tagline – ‘Cure and Beyond’, featuring cricketer MS Dhoni. In the ever-evolving world of healthcare, Emcure Pharmaceuticals...

IRLAB Bags Swedish Medical Products Agency's Nod To Perform Phase I Study

RLAB Therapeutics, a pharmaceutical firm finding and creating novel therapies for Parkinson's ailments, reported that the Swedish Medical Products Agency has endorsed the commencement of stage I clinical investigation of the medication up-and...

Lupin Bags US FDA Nod for Travoprost Ophthalmic Solution USP

Lupin Limited (Lupin) announced that the United States Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application for travoprost ophthalmic solution USP, 0.004% (ionic buffered solution), to market a generic equivalent...

Bespak and H&T Presspart Ink Pact To Advance transition To low GWP Propellants

Bespak, a main contract development and manufacturing organization (CDMO) focused on orally breathed-in and nasal drug-device gadget blend items, and H&T Presspart, a pharmaceutical firm, declared a coordinated effort to speed up the business...

Zydus biopharma Arm Buys Global Proprietary Rights For Progeria Treatment

Sentynl Therapeutics Inc (Sentynl), a US-based biopharmaceutical organization entirely claimed by Ahmedabad-settled Zydus Lifesciences, as of late finished the procurement of worldwide exclusive rights for Zokinvy. Zokinvy is the first and only...

© 2025 India Pharma Outlook. All Rights Reserved.